+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China



Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China



Zhongguo Dang Dai Er Ke Za Zhi 11(1): 5-9



Early response to therapy is one of the most important prognostic factors in childhood acute lymphoblastic leukemia (ALL). This study aimed to assess the prognostic value of morphological assessment of bone marrow blasts during remission induction and determination of minimal residual disease (MRD) after remission induction. From January 1998 to May 2003, 193 children with newly diagnosed ALL were enrolled on the ALL-XH-99 protocol. Blast cell count in the bone marrow was examined on day 19 of remission induction and by the completion of remission induction. MRD was measured with the flow cytometry. Event-free survival (EFS) was estimated by Kaplan-Meier analysis and the distributions of EFS were compared using the log-rank test. A Cox proportional hazards model was used to identify independent prognostic factors. The 4-year EFS was significantly worse in patients with > or = 5% lymphoblasts in the bone marrow on day 19 as compared to those with <5% lymphoblasts on that date (42.59%+/- 14.28% vs 74.24%+/- 6.67%; p< 0.01). The 4-year EFS was significantly worse in patients with any amount of lymphoblasts in the bone marrow on the remission date as compared to that of other patients with no morphologically identifiable blasts (63.47%+/-9.23% vs 76.41%+/- 6.09%; p<0.05). The patients with MRD <0.01 had significantly better outcome than those with a level > or = 0.01% (15-month EFS:94.44%+/-5.40% vs 23.81%+/- 20.26%; p<0.01). Early treatment response as assessed by morphological examination or minimal residual leukemia determination by flow cytometry has important prognostic significance, and can be performed in a resource-poor patient population.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055213975

Download citation: RISBibTeXText

PMID: 19149913


Related references

Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China. Leukemia and Lymphoma 49(3): 488-494, 2008

Cytogenetic and Molecular Findings in Children with Acute Lymphoblastic Leukemia: Experience of a Single Institution in Argentina. Molecular Syndromology 6(4): 193-203, 2015

Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience. Annals of Saudi Medicine 28(4): 251-259, 2008

Symptomatic Cerebral Sinovenous Thrombosis Associated With L-Asparaginase In Children With Acute Lymphoblastic Leukemia: A Single Institution Experience Over 17 Years. Journal of Pediatric Hematology/Oncology 40(7): E450-E453, 2018

Children with hyperdiploid but not triple trisomy (+4,+10,+17) acute lymphoblastic leukemia have an increased incidence of extramedullary relapse on current therapies: a single institution experience. American Journal of Hematology 83(1): 34-40, 2008

Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology 21(1): 6, 1999

Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience. Pediatric Blood and Cancer 64(10):, 2017

The Dana Farber consortium protocol (DFCP) vs. classic Hyper-CVAD for treatment of acute lymphoblastic leukemia in patients <50 Y. Single institution experience. Leukemia Research 60: 58-62, 2017

The Dana Farber Consortium Protocol for the Treatment of Adolescents and Young Adults With Acute Lymphoblastic Leukemia: A Single Institution Experience in Saudi Arabia. Clinical Lymphoma Myeloma and Leukemia 17(5): 320-325, 2017

Evaluation of early response to treatment and its prognostic value in childhood acute lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 22(2): 298-303, 2014

Acute lymphoblastic leukemia in elderly patients: a single institution's experience. Korean Journal of Internal Medicine 26(3): 328-339, 2011

Treating childhood acute lymphoblastic leukemia in a developing country 1998-2003: the experience of a single children's hospital in China. Journal of Pediatric Hematology/Oncology 28(12): 798-802, 2006

ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center. Pediatric Hematology and Oncology 29(2): 130-140, 2012

Cytogenetic analysis in childhood acute lymphoblastic leukemia: experience at a single institution in Korea. International Journal of Hematology 89(2): 150-158, 2009

Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series. Haematologica 85(8): 877-878, 2000